![John Kozarich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Kozarich
Président chez
LIGAND PHARMACEUTICALS INCORPORATED
Fortune : 10 M $ au 31/05/2026
Profil
John W.
Kozarich is currently Chief Executive Officer & Director at Nucorion Pharmaceuticals, Inc., Chairman at Ligand Pharmaceuticals, Inc., Adjunct Professor at The Scripps Research Institute, Trustee at Gordon Research Conferences, and Adjunct Professor at The University of Texas at Austin.
Former positions include Chief Executive Officer & Director at QLT, Inc., Chief Executive Officer & Director at Curza Global LLC, Chairman, President & Chief Science Officer at ActivX Biosciences, Inc., Chairman at Intec Pharma Ltd., Director at Poxel SA, Director at Adaptive Therapeutics, Inc., Independent Non-Executive Director at Corium LLC (Massachusetts), Independent Director at Travere Therapeutics, Inc., Director at Novelion Therapeutics, Inc., Vice President-Research & Development at Alkermes, Inc., Professor at the University of Maryland, Professor at Yale School of Medicine, and Vice President at Merck Research Laboratories Massachusetts LLC.
Education includes a doctorate from Massachusetts Institute of Technology and an undergraduate degree from Boston College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 42 622 ( 0,21 % ) | 10 M $ | 31/05/2026 |
Postes actifs de John Kozarich
| Sociétés | Poste | Début |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Président | 01/03/2003 |
Nucorion Pharmaceuticals, Inc.
 Nucorion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur Général | - |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Gordon Research Conferences
 Gordon Research Conferences Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that organizes scientific research conferences and seminars | Directeur/Membre du Conseil | - |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de John Kozarich
| Sociétés | Poste | Fin |
|---|---|---|
Curza Global LLC
 Curza Global LLC Pharmaceuticals: MajorHealth Technology Develops therapeutic antibiotics | Directeur Général | 01/06/2024 |
Intec Pharma Ltd.
 Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases | Président | 21/06/2021 |
| TRAVERE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2020 |
| CORIUM INTERNATIONAL INC | Directeur/Membre du Conseil | 01/04/2015 |
| ░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de John Kozarich
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
Poxel SA
 Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
ActivX Biosciences, Inc.
 ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drug molecule for hematology, oncology, metabolic and inflammatory diseases | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptive Therapeutics, Inc.
 Adaptive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Gordon Research Conferences
Gordon Research Conferences Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that organizes scientific research conferences and seminars | Commercial Services |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases | Health Technology |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
Nucorion Pharmaceuticals, Inc.
Nucorion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Curza Global LLC
Curza Global LLC Pharmaceuticals: MajorHealth Technology Develops therapeutic antibiotics | Health Technology |
